[Effect of synthesized polypeptide (P16) on inhibiting cell transdifferentiation and fibrosis induced by connective

Wei Wang1, Yu-jun Shi, Li Zhang

  • 1Key Laboratory of Transplant Engineering and Immunology, Ministry Of Health, West China Hospital, Sichuan University, Chengdu 610041, China.

Abstract

Insights

A novel peptide, P16, binds strongly to rat kidney cells and inhibits connective tissue growth factor (CTGF)-induced fibrosis. This peptide shows potential for developing new antifibrosis therapies targeting CTGF receptors.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Renal Physiology

Background:

  • Connective tissue growth factor (CTGF) plays a key role in promoting cell transdifferentiation and fibrosis.
  • Integrin αvβ3 is a known receptor for CTGF on rat tubular epithelial cells (NRK-52E).
  • Developing targeted therapies to inhibit CTGF-mediated fibrosis is a significant clinical need.

Purpose of the Study:

  • To investigate a synthetic peptide (P16) derived from CTGF for its ability to compete with CTGF binding to integrin αvβ3.
  • To evaluate the potential of P16 to inhibit CTGF-induced transdifferentiation and fibrosis in NRK-52E cells.
  • To explore P16 as a potential therapeutic agent for antifibrosis treatments.

Main Methods:

  • NRK-52E cells were cultured with CTGF, P16-FITC, or both.
  • Immunofluorescence staining and RT-PCR were used to assess the expression of α-SMA and collagen I/IV.
  • Cellular binding affinity of P16 and CTGF to NRK-52E cells was compared.

Main Results:

  • P16 demonstrated a higher affinity for NRK-52E cells compared to CTGF.
  • Co-culture with P16 significantly inhibited the upregulation of α-SMA, collagen I, and collagen IV induced by CTGF.
  • P16 alone did not induce cell transdifferentiation or fibrosis.

Conclusions:

  • The synthetic peptide P16 effectively binds to NRK-52E cells and inhibits CTGF-induced transdifferentiation and fibrosis in vitro.
  • P16 shows promise as a therapeutic candidate for antifibrosis by targeting the CTGF receptor pathway.
  • This study provides a foundation for developing novel antifibrosis therapies based on CTGF antagonism.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Forced Transdifferentiation01:28

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...